← Back to Search

Behavioral Intervention

Nutritionally Balanced Diet for Psoriasis

N/A

Recruiting

Led By Samuel T Hwang, MD, PhD

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients will have a BMI of >27

Be older than 18 years old

Must not have

Uncontrolled diabetes or blood glucose level greater than 180 mg/dl at the time of radiotracer injection

Inability to understand the risks and benefits of the study

Timeline

Screening 3 weeks

Treatment Varies

Follow Up in week 0 and week 6

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if a new PET scanner technology called EXPLORER is better at measuring inflammation in patients with psoriasis compared to older scanners. Researchers also want to see if switching from a

Who is the study for?

This trial is for people with psoriasis, a skin and joint condition. Participants should be those typically consuming a Western Diet high in saturated fats and sugars. The study will use the EXPLORER PET scanner to measure changes in their inflammation after switching to a balanced diet.

What is being tested?

The trial is testing if a nutritionally balanced diet can reduce systemic and cutaneous (skin) inflammation in psoriasis patients. It involves dietary counseling and uses advanced EXPLORER PET scanning technology to quantify inflammation before and after the dietary intervention.

What are the potential side effects?

Since this trial involves dietary changes rather than medication, side effects may include typical reactions to diet adjustment such as digestive discomfort or food cravings but are generally expected to be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My BMI is over 27.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My blood sugar is not higher than 180 mg/dl and my diabetes is under control.

Select...

I understand the risks and benefits of the study.

Select...

I am on medication for diabetes.

Select...

I can't stay still on a scanner bed for up to 60 minutes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ in week 0 and week 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~in week 0 and week 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and in week 0 and week 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Inflammation in PET/CT scan

Secondary study objectives

Cell Surface Inflammatory Markers

Microbiomes Diversity

Serum Inflammatory Markers

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Dietary InterventionExperimental Treatment1 Intervention

Participants will receive breakfast, lunch, and dinner in the form of fully cooked, ready-to-heat standardized meals for 6 weeks that are prepared by a commercial kitchen.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Dietary Counseling

2011

Completed Phase 3

~2050

0 / 5Eligibility criteria met